Austin Health

Title
MDX-060. Medarex.
Publication Date
2005-12-01
Author(s)
Hu, Xiu Feng
Xing, Pei Xiang
Type of document
Journal Article
Abstract
Medarex is developing the antibody MDX-060 for the potential treatment of CD30+ lymphomas, such as Hodgkin's disease and anaplastic large cell lymphomas. Phase I/II clinical trials were underway by December 2002.
Link
link
Citation
Current Opinion in Investigational Drugs (london, England : 2000); 6(12): 1266-71
Jornal Title
Current opinion in investigational drugs (London, England : 2000)

Files:

NameSizeformatDescriptionLink